1. From the Cancer and Disease Epigenetics Group, Murdoch Childrens Research Institute (MCRI), Royal Children’s Hospital, Parkville, Australia (BN, AC, and RS); the Department of Paediatrics, University of Melbourne, Melbourne, Australia (BN, RS, and JMC); and the Clinical Epidemiology and Biostatistics Unit (JCG) and Early Life Epigenetics (JMC and RM), MCRI, Parkville, Australia